Skip to search.
 TSX Up 0.10% TSX Ventures Down 0.25%

OncoGenex Pharmaceuticals, Inc. (OGXI)

-NasdaqCM
2.19 Up 0.04(1.86%) Apr 24, 4:00PM EDT
Add to Portfolio
Prev Close:2.15
Open:2.15
Bid:2.05 x 200
Ask:3.20 x 18200
1y Target Est:5.45
Beta:0.72
Earnings Date:Apr 28 - May 4 (Est.)
Day's Range:2.08 - 2.22
52wk Range:1.92 - 5.09
Volume:73,355
Avg Vol (3m):195,900
Market Cap:49.67M
P/E (ttm):N/A
EPS (ttm):-1.45
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
OGXIUp 1.86%49.67M
BMYDown 0.30%109.67B
CELGUp 2.26%95.04B
PFEDown 0.25%216.57B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.80
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.81
Quarterly EPS Est (Mar-15) :-0.34
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback